Sign In
Buy EDIT
$2.78
-0.0400 (-1.42%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
12:00am, Wednesday, 21'st Oct 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 20)
Aileron Therapeutics Inc (...
Global Liquid Biopsy Market Analysis and Forecast, 2020-2030 & Implications of COVID-19 Pandemic on the Market - ResearchAndMarkets.com
12:00am, Wednesday, 14'th Oct 2020
The
Nobel Prize in Chemistry Is Awarded for Crispr Gene-Editing Technology
07:42pm, Wednesday, 07'th Oct 2020
Two scientists won the Nobel Prize in Chemistry for discovering a powerful tool for genome editing that has enabled relatively quick and easy modification of the building blocks of life and promises n
Thalassemia Treatment Market Size, 2020 Growth, Types, Trends, Size, Share and Top Key Players by Forecast Research 2025
10:52am, Tuesday, 06'th Oct 2020
Oct 06, 2020 (Heraldkeepers) --
Global Thalassemia Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025. Rise in...
Systems Oncology, an AI-based Cancer Therapy Discovery and Development Company, Is Honored With a 2020 AZBio Fast Lane Award
12:00am, Wednesday, 23'rd Sep 2020
Systems Oncology is using AI to Innovate Drug Discovery & Development and is being honored with a 2020 AZBio Fast Lane Award for their achievements.
ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Sep 22, 2020 (GLOBE NEWSWIRE via COMTEX) --
ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Sept. 22,...
ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Sep 22, 2020 (GLOBE NEWSWIRE via COMTEX) -- CRISPR Therapeutics (Nasdaq: CRSP) and Vertex Pharmaceuticals...
Qihan Biotech Publishes First Clinical Xenotransplantation Prototype, ‘Pig 3.0’, in Nature Biomedical Engineering
12:00am, Monday, 21'st Sep 2020
Qihan Biotech published research reporting the successful production of its first clinical xenotransplantation prototype.
Crispr: The Frontier Of Gene Editing (NASDAQ:CRSP)
04:45pm, Friday, 18'th Sep 2020
As a premier gene-editing company, CRISPR delivered stellar animal data for the blood disorder franchises (i.e., beta-thalassemia and sickle cell disease).
Graphite Bio Launches with $45 Million Series A Financing
12:00am, Wednesday, 16'th Sep 2020
Graphite Bio today announced a $45 million Series A financing led by founding investor Versant Ventures, together with Samsara BioCapital. Graphite Bi
Editas Medicine (EDIT) Investor Presentation - Slideshow
05:45pm, Friday, 11'th Sep 2020
The following slide deck was published by Editas Medicine, Inc. in conjunction with this event..
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2020 Update
10:49am, Friday, 11'th Sep 2020
Halvorsen's 13F portfolio value increased from $19.21B to $23.14B. The number of positions increased from 64 to 71.
Editas Medicine Review Plus Now - Better Choice Of PTC Therapeutics
09:20am, Friday, 28'th Aug 2020
In Late October last year we subjected Editas Medicine to an investment behavioral analysis because its developmental approach relies on genome editing.
3 Important Things I've Learned Reviewing ARK's ETFs
10:53am, Monday, 24'th Aug 2020
ARK Invest currently offers some of the best performing ETFs over the past five years. The five actively managed ETFs provided by ARK cover innovation, autonomous technology and robotics, next generat
